Professor McMillan is a cancer biologist whose research has focused on the viral causes of cancer. He discovered the receptor for the human papillomavirus, has developed novel treatments for cancers caused by HPV, and has designed a range of novel nanoparticle delivery systems for gene silencing and editing technologies. His laboratory was the first to show that cancer could be cured in vivo using CRISPR technology in 2019. He is Professor in the School of Medical Sciences and Program Director in the Menzies Health Institute Queensland based at Griffith University’s Gold Coast Campus. Prof McMillan has had continuous NHMRC grant funding since establishing his laboratory in 1996 and has published 109 papers including papers in PNAS, Clinical Cancer Research, Oncology, Journal of Virology, Nature Nanotechnology and Nature Communications. He is past president of the Australasian Virology Society. His laboratory is currently developing therapies to treat COVID19.
Abstracts this author is presenting: